Number needed to treat to avoid progression and death and cost analysis: zanubrutinib versus acalabrutinib in relapsed/refractory chronic lymphocytic leukemia

This Research Article, published in Future Oncology, provides a detailed comparison of zanubrutinib and acalabrutinib for relapsed/refractory chronic lymphocytic leukemia patients. View the full article Abstract Aims: In the absence of head-to-head comparative trials, this study aimed to compare zanubrutinib versus acalabrutinib in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) by calculating number needed to treat … Read more

John Mauceri: Conductor Returns to Stage After Health Recovery

“`html BREAKING: John Mauceri‘s Cardiac Surgery Success BREAKING: John Mauceri’s Cardiac Surgery Success Award-winning conductor John Mauceri is back on stage after undergoing cardiac surgery to treat a… The post John Mauceri: Conductor Returns to Stage After Health Recovery appeared first on NewsyList. Source link

Maestro John Mauceri returns to the stage in renewed health

John Mauceri, an award-winning music conductor, author, and recording artist, is celebrating his return to the stage in better health following specialized cardiac surgery at NYU Langone Health to treat a rare and life-threatening heart condition. Maestro Mauceri’s illustrious career has taken him to the world’s most prestigious opera houses, symphony halls, Broadway stages and … Read more